加拿大一家公司推出前列腺癌快速诊断试剂盒

一种诊断前列腺癌的新型试剂盒提供了前列腺特异抗原的一步法检测方法，并能够在20分钟之内得到结果。

根据开发商所言，检测结果易于判断，无需额外设备或者试剂，而且结果非常精确（超过99%）。在内科医生检查之后，PSA检测需要患者去实验室接受检查，通常检查结果需要24小时甚至更长时间才能获得。这种新检测方法在医生诊疗室内即可进行，而在患者离开之前即可获得结果。

国际医疗服务公司(Edmonton, Canada)研制了这种试剂盒，该公司正致力于获得法律批准。公司相信对超过45岁的男性进行前列腺癌早期筛查有着广泛的市场。正在进行试验的第一个区域是中国。

该公司将继续利用公司员工以及科学家研发根据用于市场调研发现有着巨大潜在需求的新的检测试剂盒。通过将诊断试剂盒的类型进行多样化，该公司处于这样一个位置，即对需要特殊的检测试剂盒但是不会影响该公司的总体发展。
 
Diagnostic Kit for Prostate Cancer
 
A new kit for diagnosing prostate cancer offers a one-step prostate-specific antigen (PSA) test and provides results within 20 minutes.

The results are easy to read, require no additional instrumentation or reagents, and are very accurate (greater than 99%), states the developer. When PSA tests require patients to visit a laboratory after being examined by a physician, the test results are not obtained for over 24 hours or more. This new test can be administered in a doctor's office, with the results obtained before the patient leaves.

Medical Services International (Edmonton, Canada) developed the kit and the company is working to obtain regulatory approval. The company believes there is a significant market for an early screening test for prostate cancer in men over 45 years of age. The first area where testing is ongoing is China.

The company will continue to use its facilities and scientists to develop new test kits where market studies show there is a potential for great demand. By diversifying its types of diagnostic test kits, the company is in the position where a change in demand for a particular test kit will not affect its overall performance.